Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2009Lara D. VeekenOpen Access

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPaul A LordTFTracey FarragherManchester Academic Health Science CentreMLMark LuntVersus Arthritis

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lord et al. (2009) studied this question.

synapsesocial.com/papers/6a7d2ded166e996abdd5a59chttps://doi.org/10.1093/rheumatology/kep422
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial2006 · 881 citations
  2. 2Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)2005 · 865 citations
  3. 3The comparative one‐year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study2008 · 256 citations